ARDELYX INC. - COMMON STOCK

Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines

17 июл 2024 16:10:43 Источник Nasdaq GlobeNewswire

To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA

02 июл 2024 06:00:00 Источник Nasdaq GlobeNewswire

Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines

28 июн 2024 07:17:59 Источник Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

30 май 2024 15:02:00 Источник Nasdaq GlobeNewswire

Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

22 май 2024 07:02:00 Источник Nasdaq GlobeNewswire

Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

21 май 2024 07:02:21 Источник Nasdaq GlobeNewswire

Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)

16 май 2024 07:01:41 Источник Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

14 май 2024 15:02:00 Источник Nasdaq GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference

07 май 2024 07:01:45 Источник Nasdaq GlobeNewswire

Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update

02 май 2024 15:02:28 Источник Nasdaq GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

01 май 2024 07:00:01 Источник Nasdaq GlobeNewswire

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024

18 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

28 мар 2024 15:05:00 Источник Nasdaq GlobeNewswire

Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy

25 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

12 мар 2024 15:35:00 Источник Nasdaq GlobeNewswire

Ardelyx to Participate at the Cowen 44th Annual Health Care Conference

27 фев 2024 07:00:22 Источник Nasdaq GlobeNewswire

Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

22 фев 2024 15:01:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

12 фев 2024 08:45:08 Источник NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

09 фев 2024 08:46:16 Источник NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

08 фев 2024 08:54:40 Источник NetDania Notify